-
UPDATE: J.P Morgan Raises Its PT On Exelixis Following Earnings
Wednesday, February 23, 2011 - 10:56am | 208As Exelixis (NASDAQ: EXEL) continues its transformation into “the cabo company”, the P&L is changing rather dramatically. Taking into consideration the 143 job cuts in Dec and the exclusive spending focus on cabo going forward, EXEL's proprietary cash OpEx from continuing operations is expected...
-
Caliper and Covaris Establish Co-Marketing Agreement
Wednesday, February 23, 2011 - 9:43am | 75Caliper Life Sciences, Inc. (Nasdaq: CALP) and Covaris Inc., Woburn, Mass., today announced a co-marketing agreement which will leverage Covaris' acoustic DNA shearing platforms and Caliper's automation and microfluidics technologies to develop automated workflows for next generation sequencing...
-
UPDATE: Piper Jaffray Color ON EXEL PT Increase
Wednesday, February 23, 2011 - 9:21am | 158Piper Jaffray, which raised its PT on shares of Exelixis, Inc. (NASDAQ: EXEL), is providing some color on the stock. Exelixis is now wholly focused on bringing Cabo to the market. We look for pivotal MTC data in 1H:11 with potential Fast Track approval in 2012. Based on a positive signal, CRPC will...
-
Cleantech Stock News; Maxwell Technologies (Nasdaq:MXWL) Sees Significant Growth Opportunity for Its CONDIS Capacitive Voltage Divider Products in Russia Grid Modernization
Wednesday, February 23, 2011 - 9:00am | 36ROSSENS, Switzerland - February 23, 2011 (Investorideas.com renewable energy/green newswire) - Maxwell Technologies, Inc. (Nasdaq:MXWL) announced that a leading producer of instrument transformers for the Russian utility grid has selected CONDIS capacitive voltage dividers (CVD)
-
Cleantech Stock News; Maxwell Technologies (Nasdaq:MXWL) Sees Significant Growth Opportunity for Its CONDIS Capacitive Voltage Divider Products in Russia Grid Modernization
Wednesday, February 23, 2011 - 9:00am | 36ROSSENS, Switzerland - February 23, 2011 (Investorideas.com renewable energy/green newswire) - Maxwell Technologies, Inc. (Nasdaq:MXWL) announced that a leading producer of instrument transformers for the Russian utility grid has selected CONDIS capacitive voltage dividers (CVD)
-
JP Morgan Raises PT On Exellxis To $10
Wednesday, February 23, 2011 - 8:49am | 27JP Morgan has raised the price target on Exellxis, Inc. (NASDAQ: EXEL) from $7 To $10 and maintains its Neutral rating.
-
Piper Jaffray Raises PT On Exellxis To $13
Wednesday, February 23, 2011 - 8:25am | 27Piper Jaffray has raised the price target on Exellxis, Inc. (NASDAQ: EXEL) from $12 to $13 and maintains its Overweight rating.
-
Bruker Reports Q4 EPS of $0.28
Wednesday, February 23, 2011 - 8:17am | 55Bruker Corp (NASDAQ: BRKR) reports its Q4 EPS at $0.28, versus the consensus of $0.27. BRKR reports its Q4 revenue at $416.1 million, versus the consensus of $396.76 million. BRKR shares dropped 1.43% to close at $18.65 yesterday. Read more from Benzinga's Company news.
-
Goldman Opens QGEN With Sell
Wednesday, February 23, 2011 - 7:39am | 49Analysts at Goldman initiate coverage of Qiagen NV (NASDAQ: QGEN) with a “sell” rating. The target price for QGEN is set to $18. QGEN shares fell 0.10% to close at $20.40 yesterday. More Analyst Ratings here
-
Exelixis Reports Q4 EPS of $(0.16) vs. $(0.21)
Tuesday, February 22, 2011 - 5:48pm | 42Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and year ended December 31, 2010. Revenues for the fourth quarter ended December 31, 2010 were $40.8 million, compared to $44.1 million for the comparable period in 2009. EPS $(0.16)
-
Affymetrix Director Paul Berg to Retire
Tuesday, February 22, 2011 - 5:00pm | 46Affymetrix, Inc. (NASDAQ: AFFX) today announced that Paul Berg, Ph.D. and Nobel Laureate will retire from the Affymetrix Board of Directors in May 2011. Dr. Berg has been a board member of the company since its inception in 1993.
-
Accelr8 Announces Presentation of Preliminary Results in Pilot ICU Study
Tuesday, February 22, 2011 - 9:14am | 103Accelr8 Technology Corporation (NYSE: AXK) announced that clinical research collaborators at the Denver Health Medical Center received notification of acceptance for presentation of interim research results at the annual meeting of the American Thoracic Society. The meeting will be held in May....
-
Waters Corporation Announces up to $500M Stock Repurchase Program
Friday, February 18, 2011 - 10:54am | 65Waters Corporation (NYSE: WAT) announced today that on February 16, 2011, its Board of Directors authorized the Company to repurchase up to $500 million of its outstanding common shares over the next 24 months. The previous $500 million share repurchase program authorized in February 2009 was...
-
J.P. Morgan Provides Color On Exelixis (EXEL)
Friday, February 18, 2011 - 8:59am | 167J.P. Morgan provided color on Exelixis (NASDAQ: EXEL) in a research report published today. J.P. Morgan has previously given Exelixis a Neutral rating. In the report, J.P. Morgan states, "EXEL provided an encouraging update Wed evening from the Phase 2 trial evaluating cabozantinib (formerly XL184...
-
Piper Jaffray Raising Price Target To $12 On Exelixis, Inc. (EXEL)
Friday, February 18, 2011 - 8:46am | 120Piper Jaffray is raising its price target on shares of Exelixis, Inc. (NASDAQ: EXEL) to $12, and is keeping its Overweight rating. In a note to clients, Piper Jaffray writes, "Exelixis presented updated Phase II Prostate Cancer (CRPC) data on wholly-owned cabozantinib (XL184) at the ASCO-GU...